Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), clinical areas (Expand Search)
linear decrease » linear increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), clinical areas (Expand Search)
linear decrease » linear increase (Expand Search)
-
2141
-
2142
-
2143
-
2144
-
2145
-
2146
-
2147
-
2148
-
2149
-
2150
Changes in mRNA expression of Caspase-3, ALDH2, Bcl-2, Bax and Bcl-2/Bax in three groups.
Published 2024Subjects: -
2151
-
2152
Comparison of myocardial LC3 immunofluorescence staining of three groups (×400, scale bar = 10μm).
Published 2024Subjects: -
2153
-
2154
-
2155
Comparison of Beclin1, P62 and LC3B(II/I) protein expression levels in three groups.
Published 2024Subjects: -
2156
-
2157
-
2158
<sup>177</sup>Lu-Labeled Heterodimeric Agent with High Stability Targeting Neovascularization for Tumor Radioligand Therapy
Published 2025“…Radiopharmaceutical theranostics holds significant promise in tumor diagnosis and treatment, but suboptimal tumor uptake and retention remain a persistent limitation. …”
-
2159
-
2160